Therefore, the anti-tumor effects of regorafenib on NB may due to its combinational inhibition of RET and PDGFR-β signaling in NB cells, and the inhibition of tumor angiogenesis in the tumor microenvironment in tumor associate cells. Here, RET is linked to neuroblastoma.